Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA stock opened at $0.01 on Thursday. Calithera Biosciences has a twelve month low of $0.01 and a twelve month high of $0.13. The firm has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.02.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.